Climate Change Data

Ypsomed Holding AG

Climate Impact & Sustainability Data (2022, 2023-04 to 2024-03)

Reporting Period: 2022

Environmental Metrics

Renewable Energy Share:100%

ESG Focus Areas

  • Climate Change
  • Circular Economy

Environmental Achievements

  • Achieved a 40% reduction in GHG emissions in Step One of the Zero Programme.
  • Transitioned to sourcing 100% of its electricity from renewable sources.
  • Developed YpsoMate Zero, the world's first net zero autoinjector.

Social Achievements

  • Active founding member of the Alliance to Zero.

Governance Achievements

  • ISCC+ certified

Climate Goals & Targets

Long-term Goals:
  • Net zero emissions across the company’s entire value chain (Scope 1, 2 and 3) by 2040
Short-term Goals:
  • Net zero operational (Scope 1 and 2) CO2 emissions by 2030
  • A selection of products with net zero emissions by 2030

Environmental Challenges

  • Reducing Scope 3 emissions associated with materials (72%) and packaging (20%) in the YpsoMate autoinjector.
  • Recycling drug delivery devices due to safety and regulatory concerns surrounding medical waste.
Mitigation Strategies
  • Used chemically identical bio-based plastics for parts manufacture (mass-balance approach).
  • Used recycled polyethylene terephthalate (rPET) as a packaging tray material.
  • Investigating alternative materials such as pulp- or fibre-based packaging.
  • Developing towards circular device partnership for its disposable autoinjectors.

Supply Chain Management

Responsible Procurement
  • Working with suppliers to reduce carbon footprint of materials and packaging.
  • Encouraging suppliers to obtain ISCC+ certification.

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

  • YpsoMate Zero

Reporting Period: 2023-04 to 2024-03

Environmental Metrics

Total Carbon Emissions:87,423 t CO2e
Scope 1 Emissions:2,404 t CO2e
Scope 2 Emissions:0 t CO2e
Scope 3 Emissions:84,867 t CO2e
Renewable Energy Share:76%
Total Energy Consumption:43,214 MWh
Waste Generated:1,295 tons

ESG Focus Areas

  • Climate change & energy
  • Resource use & circular economy
  • Employee-related issues
  • Respect for human rights; Combatting corruption
  • Access to healthcare

Environmental Achievements

  • CO2 emissions reduced through NetZero program; YpsoMate 1 ml and 2.25 ml autoinjectors available as CO2-reduced products.
  • Climate targets validated by SBTi; carbon footprint validated by independent certification body for 2021 and 2022.
  • 100% renewable electricity since 2021; increased use of waste heat for heating.

Social Achievements

  • Reached 500,000 more people with injection systems; serving new therapeutic areas.
  • Awarded Swiss Employer Award; group-wide learning platform introduced.
  • Equal pay achieved for men and women; employee occupational social counselling offered.

Governance Achievements

  • Implemented Compliance Management System (CMS); Code of Conduct regularly reviewed and updated.
  • Ypsomed Integrity Line whistleblowing system established.
  • ISO 14001 and ISO 27001 certifications obtained.

Climate Goals & Targets

Long-term Goals:
  • Net-zero greenhouse gas emissions across the entire value chain by 2040
Medium-term Goals:
  • Reduce absolute GHG emissions from Scopes 1 and 2 by 90% by 2030
  • Reduce Scope 3 emissions by 97% per million CHF of value added by 2040
Short-term Goals:
  • Reduce absolute GHG emissions from Scopes 1 and 2 by 32% by 2027
  • Reduce Scope 3 emissions by 52% per million CHF of value added by 2030

Environmental Challenges

  • Supply chain disruptions (infusion sets); high competitive pressure in the pharmaceutical sector.
  • Reducing Scope 3 emissions (97% per million CHF of value added by 2040).
  • Maintaining high employee satisfaction during growth and reorganization.
Mitigation Strategies
  • Ramping up production capacities for infusion sets at contract manufacturer in Mexico and third-party supplier.
  • Comprehensive climate program (NetZero Program); sustainable procurement policy; collaboration with partners and suppliers.
  • Flexible working models; employee training and development; addressing employee concerns during transition phase.

Supply Chain Management

Supplier Audits: 20 audit days

Responsible Procurement
  • Code of Conduct
  • Supplier Code

Climate-Related Risks & Opportunities

Transition Risks
  • Regulatory changes
  • Market shifts
Opportunities
  • Development of energy-efficient products

Reporting Standards

Frameworks Used: GRI, UN SDGs

Certifications: ISO 14001, ISO 13485:2016, MDR (EU) 2017/745, MDSAP, ISCC+

Third-party Assurance: Independent external certification body

UN Sustainable Development Goals

  • SDG 3.4

Contribution to reducing premature mortality due to chronic diseases through innovative self-medication products.

Sustainable Products & Innovation

  • YpsoMate Zero 1.0 and 2.25 autoinjectors

Awards & Recognition

  • Swiss Employer Award
  • Most innovative company in Switzerland (BILANZ and Statista)